Home - Blank Rome LLP

Register to receive insights and analyses on breaking news and trends across varying industries.
<a class="link-primary mt-4" href="/subscribe">Subscribe</a>

Philadelphia, PA

New York, NY

Wilmington, DE

Cincinnati, OH

Princeton, NJ

Los Angeles, CA

Houston, TX

Tampa, FL

Shanghai

South Florida

Pittsburgh, PA

Washington, D.C.

Chicago, IL

Orange County, CA

Dallas, TX

Boston, MA

core/heading

Blank Rome partner <a href="/people/merle-m-delancey/" id="19208">Merle M. DeLancey, Jr.</a> will serve as a presenter for <a href="https://www.americanconference.com/drug-pricing/">Rx Drug Pricing &amp; Rebate Fundamentals</a>, an American Conference Institute (“ACI”) Virtual Proficiency Series program being held November 4 through December 4, 2025.

core/paragraph

ACI’s Rx Drug Pricing &amp; Rebate Fundamentals is an intensive training program that will give novices and experienced practitioners alike a thorough understanding of core pricing competencies and applicable changes in the reimbursement structures of key payor programs.

The program is designed to make attendees proficient in essential pricing and rebate concepts under Medicaid, Medicare, and other related government payor programs, including those under the auspices of PHS 340B, the Department of Veterans Affairs (“VA”), and the Department of Defense (“DOD”). The course agenda reflects the latest regulatory developments, including two major proposed rules released this summer that are poised to reshape government price reporting. These rules are part of the broader implementation of the “Big, Beautiful Bill” and include a new section focused on Medicare Part B, addressing significant changes to Average Sales Price calculations and reporting requirements.

Sessions will be held two days a week over the course of four weeks and examine:

Drug Pricing and Rebate Essentials and Introduction to Medicaid

core/list-item

PHS 340 B, VA and DoD Rx Pricing and Rebates

Medicare Pricing and Rebate Essentials and Advanced CMS Pricing and Rebate Topics

Pricing and Reimbursement for New Products and Therapies

core/list

Thursday, November 6&nbsp; |&nbsp; 3:15–4:00 p.m. EST Compendium of State Drug Price Transparency Laws State drug price transparency laws continue to proliferate across the country and bring with them additional work for government price reporting teams and risk of penalties for manufacturers. This session will:&nbsp;

Identify states with current and pending drug price transparency laws

Address challenges with finding solutions for reporting under non-uniform and sometimes conflicting state laws

Provide tips for developing a system to track and respond to these laws

Discuss the impact of these laws on Medicaid and other state pricing

Thursday, November 13&nbsp; |&nbsp; 1:00–2:15 p.m. EST A Guide to the Essentials of FSS Contracting for Pharmaceuticals with the VA and DOD

Manufacturers of innovator drugs must, and those of generic drugs may, agree to participate in the Federal Supply Schedule (“FSS”) and Veterans Health Care Act programs. While these programs may not have underwent significant change in recent years, they remain important programs to manufacturers and carry with them detailed program requirements. This session will cover:&nbsp;

The overall obligations of manufacturers contracting with the federal government with respect to:

What entities are entitled to the FSS price

The significance of being a single v. dual pricer

How the Federal Ceiling Pricing and FSS price are determined

How non-Federal Average Manufacturer Price is calculated

For more information and to register, please visit the&nbsp;<a href="https://www.americanconference.com/drug-pricing/">event webpage</a>.

6th Annual Passport to Proficiency on Rx Drug Pricing & Rebate Fundamentals

Offices

Stay Connected

Slide Menu

Slide Search

6th Annual Passport to Proficiency on Rx Drug Pricing & Rebate Fundamentals

Offices

Stay Connected